Pål Ryfors

PÅL RYFORS – CEO

@palryfors

Born: 1983

Pål has a Bachelor in Financial Economics from Gothenburg School of Economics. He has vast experience from leading positions within the finance and banking sector both in the Nordics and internationally.

Pål has been CFO of Marginalen Bank, a Swedish bank employing some 350 people. Prior to that, he was Head of Group Controlling at Hoist Finance. Before joining Hoist Finance, he was an investment banker at Societe Generale in London, a position he assumed after holding several leading positions in the restructuring of the Swedish operations of Kaupthing Bank.

Other appointments: Chairman Aros Kapital, Board member Vivesto AB (publ)

No of B shares: 3,000,000

No of employee stock options: 872,734

No of performance options: 2,856,732

No of warrants: 1,661,427

 

 

 

Veronica Wallin

VERONICA WALLIN – CFO

Born: 1986

Veronica has a Degree of Master of Science in Business and Economics from Stockholms University and was employed by Episurf Medical in August 2016 as Head of Finance. In June 2017 Veronica became CFO after Pål Ryfors, who then resigned as CFO.

Prior to joining Episurf Medical Veronica worked as Head of Finance at ApoEx during 2013-2016.

Other appointments: Board member Alligator Bioscience AB (publ), Board member IRLAB Therapeutics AB (publ) and Integrative Research Laboratories Sweden AB.

No of B shares: 112,000

No of employee stock options: 140,000

No of performance options: 998,086

No of warrants: 10,000

 

 

 

 

 

KATARINA FLODSTRÖM – COO

Born: 1975

Katarina has a PhD in Physical Chemistry from Lund University and a MSc in Chemical Engineering from the Royal Institute of Technology in Stockholm. She was employed by Episurf Medical in 2014. Katarina has more than 15 years’ experience from RnD in start-up companies. She was the RnD Manager and Quality Manager of Diamorph AB from which Episurf is a spin-off.

Other appointments:-

No of B shares: 103,125 (of which 28,875 is family members)

No of employee stock options: 140,000

No of performance options: 985,295

No of warrants: 10,000

 

 

 

 

Fredrik Zetterberg

FREDRIK ZETTERBERG – MARKETING DIRECTOR

Born: 1975

Fredrik was employed by Episurf Medical AB in February 2016 and has 25 years of experience from medical technology companies such as Baxter, Cardinal Health, ArthroCare and Smith & Nephew.

Since 2008 the focus has been on orthopedics where he has held senior positions within sales management and international marketing.

Other appointments:-

No of B shares: 26,500

No of employee stock options: 140,000

No of performance options: 998,049

No of warrants: 10,000

 

 

 

 

 

MICHAEL NÄSSTRÖM – HEAD OF QUALITY & REGULATORY AFFAIRS 

Born: 1989

Michael has a Master of Science in Medical Engineering from the Royal Institute of Technology in Stockholm and was employed by Episurf Medical in October 2018.

Previously Michael has been working as a consultant within the life science and medical device industry.

Other appointments:-

No of B shares: 4,000

No of employee stock options: 140,000

No of performance options: 461,941

No of warrants: 10,000

 

 

 

PATRICK JAMNIK – PRESIDENT, EPISURF MEDICAL INC 

Born: 1983

Patrick has almost 20 years of global market development experience, building businesses across multiple orthopaedic disciplines in both Europe and the US. He has previously held commercial leadership positions at Stryker, Zimmer-Biomet, Stanmore Implants, and InspireMD. While at UK-based Stanmore Implants, he played a central role in establishing, commercialising, and growing its US business, leading to its eventual acquisition by Stryker. Patrick has a Bachelor’s Degree and MBA from the University of Wisconsin-Madison.

Other appointments:-

No of B shares: 68,050

No of employee stock options: –

No of performance options: 797,735

No of warrants: –

 

 

 

STEPHEN CASWELL – HEAD OF SALES, OUS

Born: 1981

Stephen has a mix of clinical and commercial experience, practicing as a Physiotherapist for 11yrs, working in both the U.K public and private sectors before leading his own practice and team.

Following his time as a Physiotherapist, Stephen also spent 7 years with Stryker in their Joint Replacement division in various roles covering direct sales, sales management, Mako Robotics Marketing and as Commercial Director of Strategic Capabilities.

Stephen has a BSc First Class Hons degree in Physiotherapy, Post Graduate Diploma in Orthopaedic Medicine, MSc in Sports and Exercise Medicine and an Executive MBA.

Other appointments:-

No of B shares: –

No of employee stock options: –

No of performance options: 579,849

No of warrants: –

Updated 2023-06-21